₹33.00
-1.90 (-5.44%)
As of 21 Sept 2026, Goldline Pharmaceutical Ltd share price is ₹33.00. The stock opened at ₹33.00 and had closed at ₹34.90 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹33.00 and a high of ₹60.00. In terms of performance, Goldline Pharmaceutical Ltd share price has decreased by 10.56% over the past six months and has decreased by 38.52% over the last year.
Goldline Pharmaceutical Stock Price Chart
Goldline Pharmaceutical Ltd Overview
Market cap₹34 Crs
Volume42,000
Prev. Close₹34.90
Year range₹33.00 - ₹60.00
ISININE1CLW01015
About Goldline Pharmaceutical
Goldline Pharmaceutical are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.”
Goldline Pharmaceutical Ltd Historical Performance
1 Month Return-12.95%
6 Month Return-
3 Year Return-
3 Month Return-20.08%
1 Year Return-
5 Year Return-
Goldline Pharmaceutical Ltd Fundamentals
ROCE(TTM)28.35%
P/E Ratio (TTM)0.00
P/B Ratio1.39
Debt to Equity0.64
ROE28.89%
EPS (TTM)0.00
Dividend Yield0.00%
Book Value25.05
Profit Margin15.95%
Operating Margin0.00%
Goldline Pharmaceutical Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 |
|---|---|---|---|
| Revenue | 31.20 | 28.06 | 23.57 |
| EBITDA | 6.94 | 5.83 | 4.30 |
| Net Profit | 4.12 | 2.83 | 1.81 |
| EPS | 5.97 | 4.11 | 4.39 |
Goldline Pharmaceutical Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 34.41 |
| Resistance 1 (R1) | 35.19 |
| Pivot Point | 34.71 |
Goldline Pharmaceutical Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| AMOL LAXMIKANT MUJUMDAR | Chairman |
| Swapan Prernprakash Khandelwal | WTD & Executive Directorector |
| Prashant Shriknshna Karkare | Executive Directorector |
Goldline Pharmaceutical Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.90+1.72% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,410.50+0.38% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,970.00+2.69% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Goldline Pharmaceutical Ltd today is ₹33.00 on NSE and ₹33.00 on BSE.
- The 52-week high of Goldline Pharmaceutical Ltd is ₹60.00, while the 52-week low is ₹33.00.
- The current market capitalisation of Goldline Pharmaceutical Ltd is approximately ₹34 crore.
- The P/E (Price-to-Earnings) ratio of Goldline Pharmaceutical Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Goldline Pharmaceutical Ltd is 1.39. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Goldline Pharmaceutical Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Goldline Pharmaceutical on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Goldline Pharmaceutical Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Goldline Pharmaceutical Ltd comprises different categories of shareholders. As of May 2026, the shareholding is approximately 57.29% promoters, 5.16% FIIs, 7.81% DIIs, and 25.14% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
